Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas.
about
In Vivo Noninvasive Imaging for Gene TherapyProdrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant gliomaAlpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinomaNovel delivery strategies for glioblastomaImaging: guiding the clinical translation of cardiac stem cell therapyIn vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac deliveryPET/MRI for neurologic applications.Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas.Imaging in neurooncologyHuman gene therapy and imaging in neurological diseases.Selective delivery of therapeutic agents for the diagnosis and treatment of cancer.Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET.Optimizing the success of cell transplantation therapy for stroke.Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil.Molecular imaging of transcriptional regulation during inflammationStem cell based gene therapy in prostate cancerMolecular brain imaging in the multimodality era.Redesigning human 2'-deoxycytidine kinase enantioselectivity for L-nucleoside analogues as reporters in positron emission tomographyUse of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus.Positron emission tomography image-guided drug delivery: current status and future perspectives.Suicide genes: monitoring cells in patients with a safety switch.AEG-1 promoter-mediated imaging of prostate cancer.Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expression.Quantum mechanics/molecular mechanics investigation of the mechanism of phosphate transfer in human uridine-cytidine kinase 2.Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expressionHighly penetrative, drug-loaded nanocarriers improve treatment of glioblastomaMolecular-genetic imaging: current and future perspectives.Functional imaging for assessment of therapy.Novel central nervous system drug delivery systems.Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging.Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo.HaloTag: a novel reporter gene for positron emission tomography.Translational molecular imaging for cancer.Workshop on the production, application and clinical translation of ''non-standard'' PET nuclides: a meeting report.Prospects and RISC score of viral gene therapy for sarcoma.Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.Gene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects.Molecular imaging of gene therapy for cancer.Role of reporter gene imaging in molecular and cellular biology.
P2860
Q24790997-37CD1C5E-0F45-4721-B716-BA50A2AF020DQ24792836-5D8FF625-D728-4206-9936-D7B5F141E419Q24802324-7961F909-867F-410D-99B8-6EF9063F0B17Q26741197-74208198-14DF-4555-9792-145E030D16CAQ27006099-2E93481A-FBD7-4717-AE1D-B66D0EB969B0Q27008410-EAC32A39-4506-47E2-B1A9-37C562EAED26Q27339181-18AA1293-122E-4DC8-8495-B10DE336176BQ30577115-F7DED3C4-D1C5-4F35-9F6D-1FBEFF87C7A1Q30775012-2B8BA1B7-8A0A-4615-A674-68F3C0D97A02Q30989939-57FB90FA-4161-42D0-ABFF-348ADD21B62FQ31023442-6B2DF06C-2875-4D78-969A-9F7D243F1577Q33230098-8B8761BA-C966-487A-84F1-19E2D7C2737AQ33416415-3CEB8458-1B57-4DD2-BC8C-110DB04D7F52Q33636930-FBFA02AC-C562-42C1-AE90-6273FD446911Q33762809-EC9B29E5-5F58-4C4E-A894-DCB76E3D36C0Q33907256-9AB4B16C-ACC3-4C6C-9AF9-443DF13B920FQ33997951-44BF1656-3D99-47EE-A45F-DB8E21D3C078Q34204125-0EC2B1C6-7569-489D-ADAC-427F9593D926Q34361054-72CA710F-0975-40EB-825A-2EB7C15B15DEQ34441869-3DAE9A2F-D8D1-4D03-9AA9-B27B64B8DCE2Q34446108-FE6F022D-C119-4DB8-9977-5DF7CF627C01Q34462056-AA72D581-FC9D-48E8-836B-A078C5802F3DQ34522714-EA85C71C-5166-41FD-B083-463569105EDBQ34536737-19DB1D6E-9882-4549-B8B7-19ADDCE2D6CBQ34624976-3A9A2D5B-B7E3-48B4-AF33-6EA7C46CDD85Q34674065-E60FB71E-A807-4926-BDA3-07ED06A21E38Q34789136-ED09CB08-BF8F-4187-B154-73D9AB0B347EQ35019503-128BC7DA-B8E2-47B9-AFE7-D309AC3CAB2BQ35041962-AC9196C3-3B02-4C8F-B549-40573258FF08Q35064473-3EF7A662-1391-41AA-8A33-9335E6778412Q35068110-15C5AE5F-1DEC-4D09-8C42-E72EF3278F4CQ35127438-C044F6F7-0245-4D67-8DDE-895E2331CE1EQ35172566-91E5A24A-D9FA-4E46-9D4B-BD67586CAA43Q35173093-6037B602-0B46-4803-A2BA-1C189236B76CQ35546196-B219007C-A18E-4421-91D7-8E2D34C3D7FDQ35594072-7BF64E93-F4DB-4E9F-BC58-7109393916C4Q35609066-5EB7EFB8-239A-4A20-BC37-3966B7B28E24Q35623922-BBF2107F-0A12-4252-BF71-9CCAE45840F6Q35772207-01CC8025-5837-4446-A64B-1D57C7ED3447Q35804335-3331619D-2112-4EFF-A270-E0AAFC5C76A7
P2860
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Positron-emission tomography o ...... n in gene therapy for gliomas.
@en
Positron-emission tomography o ...... n in gene therapy for gliomas.
@nl
type
label
Positron-emission tomography o ...... n in gene therapy for gliomas.
@en
Positron-emission tomography o ...... n in gene therapy for gliomas.
@nl
prefLabel
Positron-emission tomography o ...... n in gene therapy for gliomas.
@en
Positron-emission tomography o ...... n in gene therapy for gliomas.
@nl
P2093
P1433
P1476
Positron-emission tomography o ...... n in gene therapy for gliomas.
@en
P2093
A Gossmann
K Wienhard
P304
P356
10.1016/S0140-6736(01)05904-9
P407
P577
2001-09-01T00:00:00Z